Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Fifty years after the Food and Drug Administration approved the first hormonal contraceptive for use in the United States, most people say the pill has made women's lives better while the debate about how sexual attitudes have changed is less conclusive.
Under current law, the U.S. Department of Defense automatically faces significant spending cuts over the next 10 years—cuts that america's civilian and military leaders have cadidly described as "devastating" and "very high risk."
The search for better anti-addiction medications is worthy, but we have to be realistic. The passive model of drug treatment for addiction is a pipe dream.
Patients claiming they were harmed byMerck's drugare likely to prove that the company tried to sit on hard medical evidence with hopes that it could run out the clock on its drugs' patent.
Everybody who pays attention to these sorts of things knows Muslim societies are almost uniquely immune to the forces that have been driving down fertility rates on every continent for decades. But everybody, it seems, fell asleep before the final act.
Reviewing "The Myth of The Paperless Office" for the New Yorker in 2002, Malcolm Gladwell argued that if the computer had come first, and paper didn't exist, someone would have had to invent it. Paper, it turns out, is a lot more useful than we typically appreciate.
Is there a compromise on campaign finance reform that could achieve broader support and satisfy the bottom line of reformers to improve the broken system?
AEI resident fellow JD Kleinke, an expert on health care business strategy and entrepreneurship offers a fresh perspective on the recent fracas over insurance mandates to cover contraception.





